Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Gut|June 1, 2018
Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's diseaseHeike Schmitt, Ulrike Billmeier, Walburga Dieterich, et al.
Virchows Archiv : an International Journal of Pathology|May 10, 2023
Round-Robin test for the histological diagnosis of acute colonic Graft-versus-Host disease validating established histological criteria and grading systemsKatrin Hippe, Andreas Kreft, Simone Reu-Hofer, et al.
Immunity|August 27, 2011
CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenesBrian T Edelson, Tara R Bradstreet, Kai Hildner, et al.
Gastroenterology|August 31, 2011
Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophagesRaja Atreya, Michael Zimmer, Brigitte Bartsch, et al.
Frontiers in Immunology|May 28, 2020
ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory FailureAnja Schulz-Kuhnt, Vicky Greif, Kai Hildner, et al.
Inflammatory Bowel Diseases|June 14, 2022
Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton ImagingLucas Kreiss, Oana-Maria Thoma, Sarah Lemire, et al.
Nature|July 7, 2009
The AP-1 transcription factor Batf controls T(H)17 differentiationBarbara U Schraml, Kai Hildner, Wataru Ise, et al.
Scientific Reports|October 22, 2015
Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic miceBart Legein, Edith M Janssen, Thomas L Theelen, et al.
Scientific Reports|May 28, 2020
Author Correction: Ablation of CD8α+ dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic miceBart Legein, Edith M Janssen, Thomas L Theelen, et al.
The Journal of Clinical Investigation|April 17, 2003
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytesImke Tiede, Gerhard Fritz, Susanne Strand, et al.
Pageof 6